Contact
searchSearch
HMP Global

Health Care Policy and Legislation

commentary


Alex Sommer
Commentary
What Insurance Plans Need to Know About Biomarker Legislation
02/14/2024
Biomarker bills are merely the latest in what is likely to be a wave of legislation mandating coverage of new tests and therapies that are part of the growth in precision medicine. This will make it increasingly difficult for plans to control...
Biomarker bills are merely the latest in what is likely to be a wave of legislation mandating coverage of new tests and therapies that are part of the growth in precision medicine. This will make it increasingly difficult for plans to control...
Biomarker bills are merely the...
02/14/2024
First Report Managed Care
Headshot of Cory Busse, Icario
Commentary
2024 CMS Final Rule: Focus on the Health Equity Index Reward
05/04/2023
In this commentary, Cory Busse, vice president, sales and strategic solutions, Icario, shares insight into the Health Equity Index (HEI) reward in the 2024 CMS Final Rule and what Medicare Advantage plans should do next.
In this commentary, Cory Busse, vice president, sales and strategic solutions, Icario, shares insight into the Health Equity Index (HEI) reward in the 2024 CMS Final Rule and what Medicare Advantage plans should do next.
In this commentary, Cory Busse,...
05/04/2023
First Report Managed Care
Headshot of Cory Busse, Icario
Commentary
2024 CMS Advance Notice: Impact to Star Ratings, Focus on Health Equity, Part D, and Inflation Reduction Act
02/07/2023
In this commentary, Cory Busse, vice president, sales and strategic solutions, Icario, reviews key takeaways for health plans from the Centers for Medicare & Medicaid Services' 2024 Advance Notice.
In this commentary, Cory Busse, vice president, sales and strategic solutions, Icario, reviews key takeaways for health plans from the Centers for Medicare & Medicaid Services' 2024 Advance Notice.
In this commentary, Cory Busse,...
02/07/2023
First Report Managed Care
Icario logo
Commentary
How the Updated CMS Health Equity Framework Will Improve Member Experience in Light of SDoH
02/02/2023
Icario Team
The Icario team breaks down the latest CMS framework on health equity and offers insight on how health plans can make effective change in their latest blog.
The Icario team breaks down the latest CMS framework on health equity and offers insight on how health plans can make effective change in their latest blog.
The Icario team breaks down the...
02/02/2023
First Report Managed Care
Headshot of Troy Jelinek, Icario
Commentary
2024 CMS Proposed Rule: 5 Key Takeaways and Next Steps
01/03/2023
In this commentary, Troy Jelinek shares key points from the Centers for Medicare & Medicaid Services' 2024 proposed rule, including measure changes that will impact Star Ratings and member engagement in the years to come.
In this commentary, Troy Jelinek shares key points from the Centers for Medicare & Medicaid Services' 2024 proposed rule, including measure changes that will impact Star Ratings and member engagement in the years to come.
In this commentary, Troy Jelinek...
01/03/2023
First Report Managed Care
Headshot of Kyle Probst, Coix Health
Commentary
State Reproductive Health Laws and Patient Privacy
12/22/2022
Kyle Probst, deputy general counsel and director of government relations, Ciox, details actions some states have taken to enact reproductive privacy laws and proposes considerations for providers to keep in mind as they seek to protect...
Kyle Probst, deputy general counsel and director of government relations, Ciox, details actions some states have taken to enact reproductive privacy laws and proposes considerations for providers to keep in mind as they seek to protect...
Kyle Probst, deputy general...
12/22/2022
First Report Managed Care
Headshot of Steve Wigginton, Icario
Commentary
Three Health Care Predictions for 2023: New Realities and Priorities for Health Plans
11/30/2022
In this commentary, Steve Wigginton, CEO, Icario, predicts what 2023 may have in store for health plans, with a focus on the end of the public health emergency, member satisfaction, and social determinants of health.
In this commentary, Steve Wigginton, CEO, Icario, predicts what 2023 may have in store for health plans, with a focus on the end of the public health emergency, member satisfaction, and social determinants of health.
In this commentary, Steve...
11/30/2022
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

John Hennessy Headshot
Videos
Biosimilars, Explained
10/24/2023
In this video, John Hennessey, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
In this video, John Hennessey, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
In this video, John Hennessey,...
10/24/2023
First Report Managed Care
News
The Toxic Effects of Tea Tree Oil for Treatment of Demodex Mites
11/16/2023
“Our findings show that T4O causes a dose- and time-dependent decrease in cell survival of immortalized human meibomian gland epithelial cells,” said researchers.
“Our findings show that T4O causes a dose- and time-dependent decrease in cell survival of immortalized human meibomian gland epithelial cells,” said researchers.
“Our findings show that T4O...
11/16/2023
First Report Managed Care
News
Comfort, Interest, and Therapy Choices Differ Between Hidradenitis Suppurativa Experts and Non-Experts in Complex Cases
12/20/2023
“Although North American guidelines for HS management were recently published in 2019 from both the United States and Canadian HS Foundations, barriers to HS expertise among dermatologists still exist,” wrote coauthors.
“Although North American guidelines for HS management were recently published in 2019 from both the United States and Canadian HS Foundations, barriers to HS expertise among dermatologists still exist,” wrote coauthors.
“Although North American...
12/20/2023
First Report Managed Care
News
What Do the Drug Price Changes Announced in January Tell Us?
02/14/2024
The initial findings regarding the changes in prescription drug prices for 2024 have arrived. In this summary, we’ll outline shifts and seek insights from Edmund J Pezalla, MD, founder and CEO, Enlightenment Bioconsult, examine underlying...
The initial findings regarding the changes in prescription drug prices for 2024 have arrived. In this summary, we’ll outline shifts and seek insights from Edmund J Pezalla, MD, founder and CEO, Enlightenment Bioconsult, examine underlying...
The initial findings regarding...
02/14/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use